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ABSTRACT
Cooper, Jared Owen. Ph.D. The University of Memphis. May 2013.
Development of a Mechanically-Stimulated Tissue-Specific Extracellular Matrix Coated
Scaffold for Tendon/Bone Interface Engineering. Major Professor: Warren O. Haggard,
Ph.D.
The enthesis is a complex anatomical and functional interface between tendon and
bone. Once injured, this site does not readily heal and is repaired with limited success.
To aid in repair of the enthesis a commercially available scaffold was chosen, from 3
candidate biomaterials, with fibroblast and osteoblast deposited extracellular matrix
(ECM) to create a tendon and bone region, respectively, on the scaffold. To further
enhance the ECM deposition, the seeded scaffold was mechanically stimulated in a
custom built bioreactor for 35 days. The scaffolds were then evaluated by looking at
tissue specific gene activation of mesenchymal stem cells (MSC)s due to the deposited
ECM.
Out of the three materials, non-degradable polyester fabric (PET), degradable
polylactic acid (PLA) fabric, and biologic acellular dermal matrix (ACDM), the PLA
fabric had the best combination of ECM deposition and mechanical strength for the
project. After selecting a scaffold, we determined the parameters for co-culture medium,
with respect to fibroblast and osteoblast mineralization. It was determined that standard
growth medium, alpha-MEM + 10% fetal bovine serum + 1000 U/mL penicillin, 1000
μg/mL streptomycin, 2.5 μg/mL amphotericin-B + 3 mM beta-glycerophosphate + 25
μg/mL of ascorbic acid provided low fibroblast mineralization while still allowing for
osteoblast mineralization. Fluorescence imaging demonstrated that a co-cultured scaffold
could be seeded to produce two distinct tissue specific regions. The transition zone
produced had values for collagen and glycosaminoglycan (GAG) deposition between that
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of the two tissue specific regions. Lastly after mechanical conditioning, stimulating the
entire scaffold produced an increase in cell number, and the ratio of collagen to GAG in
ECM compared to static culture. When the MSCs were exposed to the tissue specific
regions, entirely stretched ECM caused an increase in collagen and tendon-specific GAG
gene activation and a decrease in mineralization gene activation compared to tissue
culture plastic. Cartilage specific markers were unchanged.
In conclusion, a suitable commercially available scaffold was identified. The
scaffold was seeded so a tendon specific and bone specific regions were distributed on
the scaffold. Mechanically conditioning the scaffolds in a bioreactor increased the
activation of tissue specific genes for tendon and bone compared to stem cells seeded on
tissue culture plastic. Future work includes a functional scaffold testing in an in vivo
tendon-to-bone animal model.
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PREFACE
This body of research was funded by a Department of Defense PRORP Grant,
Award # W81XWH-10-1-0768 entitled “Enhanced soft tissue attachment and fixation
using a mechanically-stimulated cytoselective tissue-specific ECM coating”. Outlined in
this grant was the basis for the organization of the research performed here. The purpose
of this research was to apply modern tissue engineering techniques with commercially
available biomaterials to aid in repair of tendon-to-bone injuries. Many soft tissue
injuries occur in the civilian realm; however with rising incidences of injured soldiers, the
Army is interested in providing functional care to more quickly to rehabilitate these
wounded warriors. The main body of this dissertation contains the following manuscripts
which will be submitted for publication as noted:
Chapter 2: Scaffold Considerations for Tendon/Bone Interface Engineering. Planned
submission to Journal of Functional Biomaterials (APR 2013).
Chapter 3: Co-Cultured Tissue Specific Scaffolds for Tendon/Bone Interface
Engineering. Planned submission to Journal of Orthopedic Research (APR 2013).
Chapter 4: Mechanically-Stimulated Co-Cultured Tissue-Specific Scaffolds for
Tendon/Bone Interface Engineering. Planned submission to Journal of Biomedical
Materials Research Part B: Applied Biomaterials (APR 2013).
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CHAPTER 1: INTRODUCTION
Anatomy and Problem
The enthesis (or tendon/ligament to bone interface) is a complex tissue interface
that attaches tendon or ligament to bone1. This interface is a continuous transition from
tendon or ligament, to non-mineralized fibrocartilage, to a mineralized fibrocartilage to
bone1-3. The function of the enthesis is to transfer loads from tendon to bone, both of
which have different mechanical properties2,4. Much of how the mechanical loads are
transferred is due to the anatomical specificity of the tissue shown in Figure 14. Tendon
is comprised of highly aligned collagen fibers in the direction of mechanical loading4,5.
Most of the tendon fibers are composed of collagen type I and type III as well as
approximately 2-4% elastin4-6. There are also proteoglycans such as decorin and
biglycan that act as crosslinkers within the tendon extracellular matrix (ECM) to aid in
increased mechanical strength4,7. This ECM is maintained by specialized fibroblasts
called tenocytes. Fibrocartilage is comprised of mostly collagen type II, with small
amounts of collagen type III and less collagen type I and type X4,5,7. The collagen fibers
become larger and alignment becomes less organized from tendon to fibrocartilage.
Ovoid but aligned cells appear and there are higher amounts of aggrecan compared to
other proteoglycans present in the fibrocartilage4,8. This layer transitions into mineralized
fibrocartilage where round chondrocytes are present in a mineralizing matrix containing
collagen type II and high amounts of collagen X and aggrecan5,7. The collagen matrix in
the mineralizing region is much less organized than the fibrocartilage and tendon.
Finally, bone is comprised of highly mineralized unaligned collagen type I matrix and no
collagen type II4. This matrix is maintained and remodeled by osteoblasts, osteoclasts,
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and osteocytes7. This gradual transition from highly aligned non-mineralized tendon to
low alignment and high mineralization bone is important to relieve stress concentrations
that could form between an abrupt transition from tendon to bone5. Even so, there are
sites in the body that are prone to injuries at the enthesis. Notably these are the
supraspinatus tendon in the rotator cuff of the shoulder and the anterior cruciate ligament
(ACL) in the knee.
The rotator cuff is an arrangement of tendons that help stabilize the glenohumeral
joint of the shoulder9. There are high numbers of injuries of the rotator cuff as people
age. It has been estimated that 17 million people have rotator cuff tears and greater that
30% of the population over the age of 60 years have a rotator cuff tear of which 7-27%
are full thickness tears and 13-37% are partial thickness tears5,9,10. To repair these
injuries, approximately 75,000 surgeries are performed in the United States each year5,10.
However, there is no gold standard for the treatment of rotator cuff tears. This is because
of the complex anatomy of the shoulder and the relatively avascular tendons in the rotator
cuff that do not lend to natural healing9,10. The most common method for repair is to
secure the tendon to the humeral head with sutures and suture anchors, followed by
extensive rehabilitation therapy5,11. However, these methods have a reported failure rates
of 20-70%9-12. Even though the torn tendon is effectively replaced at its anatomic
footprint, the functional interface is not regenerated5. It is the goal of rotator cuff repair
is to restore the anatomic insertion of the tendon attachment which is the same goal for
ligament repair.
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The ACL is the most commonly injured ligament in the knee with an estimated
100,000 reconstructions per year in the United States and this number is steadily rising
especially in the aging and the increasingly active younger populations3,5,7. Injury to the
ACL causes instability of the knee and causes complications if not treated. Similar to the
rotator cuff, the ACL is avascular and does not heal naturally3,7. For severe tears,
primary reattachment is difficult so autografts or allografts are used. The most common
graft is a bone-tendon-bone (BTB) graft taken from the patella and tibia in the knee of a
cadaver or patient5,13. A bone tunnel is formed at the injured site between the femur and
the tibia and the bone portion of the BTB is secured in the tunnel13. Another common
technique is to harvest a hamstring tendon from cadaver or patient and secure it in the
bone tunnels between the femur and tibia5,13. Successful repair can be achieved with
these methods but also come with additional problems. Autografts are associated with
additional patient surgeries, donor site morbidity, chronic joint pain, and
osteoarthritis3,5,7,14. Allografts do not have these problems but do have limited
availability, increased cost with sterilization, possible donor sourced pathogens, and
decreased biological and mechanical properties through tissue processing3,5,14. The
disadvantages of current graft methodologies reveal a clinical need to develop a graft that
has the mechanical properties to transfer loads between tendon and bone while having the
biologic capability to regenerate the anatomical interface needed for functional
attachment. Biomaterial and cell based tissue engineering techniques have been used to
address this problem15. In addition with the similarities between tendon and ligaments,
with respect to anatomy, attachment site, and healing behaviors, a single technology
developed for one could easily be modified for use with the other.
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Current Research Strategies
Tissue engineering is the application of biomaterial scaffolds, cells, and signals to
create a tissue in vitro16. Tissue engineering techniques are the primary method used in
research to address enthesis repair and each component has an impact on what tissue is
formed and how that tissue functions13,17. The purpose of the scaffold to act as a threedimensional structure to allow cell attachment, cell migration, expression of cell signals,
ECM deposition, and transfer of mechanical loads from surrounding tissues6,18,19.
Ideally, this biomaterial matches the mechanical properties of the tissue being engineered
and is degradable so that as the biomaterial scaffold is broken down, regenerated tissue is
replaced. However, typically these two characteristic are inversely related with respect to
mechanical properties11. Even so, commercially available synthetic materials used for
tendon-to-bone repair include and non-degradable and degradable polymers. Nondegradable materials include polyester terepthalate (PET), polytetraflouroethylene
(PTFE), and polypropylene (PP) and polycarbonate poly(urethanurea)10,20-23 and
degradable synthetic materials include poly(urethaneurea), and polylactic acid (PLA)
10,12,19

. These synthetic materials are attractive as scaffolds because material processing

allows for control in 3-D structure and porosity which can have large impact on the tissue
integration and mechanical properties of the repair. ECM is also a powerful signaler for
tissue regeneration, so biologic ECM-based scaffolds have been considered2,24.
Commercially available biologic ECM based materials include acellular dermal matrices
(ACDM) from human, bovine, porcine, or equine sources9-11,25. These materials have
shown rapid degradation and tissue integration but do not have the mechanical properties
necessary to address functional loading. The scaffold needs to have tissue-specific
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structural features for functional repair but also needs to be compatible with tissuespecific cell types.
Cells are important in tissue repair as they are responsible for matrix remodeling
and tissue maintenance4. Most cell types have been differentiated to a specific function
depending on the tissue. For tendon and ligaments, the primary cells are specialized
fibroblasts, cartilage and fibrocartilage tissues contain chondrocytes, and bone has
osteoblasts and osteoclasts. One strategy for cell selection in tissue engineering is to
choose the fully differentiated cell type to deposit the ECM on the scaffold26. This is an
attractive choice because these cell types tend to deposit mimetic ECM components seen
in the natural tissue26. However, some specialized cells, such as tenocytes, have low
metabolic activity, proliferate slowly, and are more suited for ECM maintenance rather
than regeneration. Other fibroblast sources, such as dermal fibroblasts have been
investigated for tendon and ligament repair27. Results showed that the dermal fibroblasts
did produce ECM similar to the native ECM27. For bone tissue engineering typically
only osteoblasts, bone forming cells are used in the absence of osteoclasts, bone
resorbing cells. The other cell selection is an undifferentiated cell source. Specifically,
for musculoskeletal tissues, mesenchymal stem cells (MSC) are used6. MSCs are adult
stem cells that can differentiate into different cells types depending on the growth factors,
cytokines, and ECM present24. MSCs are also metabolically active and deposit collagens
readily24. However, MSCs need specific growth factors or chemical signals to fully
differentiate into a specific cell type6. As of yet there are no established best cell type for
each tissue. Many combinations of scaffold and cell type have the potential to show
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tissue regeneration but depends on how the scaffold and cells signal the tissue to
regenerate.
Extracellular matrix, growth factors, and mechanical stimuli are the signals that
communicate to the body what to activate or deactivate in order to repair or regenerate
the injured site24. Each cell type responds to specific combinations of signals from the
extracellular environment to maintain or repair the tissue. Once these signals are
identified they can be isolated, purified, and re-introduced into the tissue or cell
environment, sometimes with dramatic effect24. For example, bone morphogenic protein2 (BMP-2) is one growth factor that is commonly used for bone regeneration and when
introduced into a muscle pouch is able to induce bone formation in the surrounding
tissue. Similar responses with respect to tendon have been observed in tendon repair with
the growth factor, BMP-12. Other growth factors are equally effective for their specific
task2. In addition, mechanical stimuli can have a large impact on tissue response2. The
classic example of how mechanical forces can affect tissues is Wolff’s law in bone28.
Essentially, bone will remodel according the forces acted upon the bone, so increases in
cyclic forces will induce bone formation and decreases in stimulation will enhance bone
resorption. There is also a similar response in tendon and soft tissues where tendon mass
and ultimate strength increases with increased use and vise versa2,29. These techniques
have been utilized by highly controlled mechanical strains systems to accurately control
the application forces, the strain rates, the number of cycles, temperature, gas exchange,
and remain sterile while in operation 2,11,30. How these parameters are actually controlled
is varied, but several researchers have taken on the challenge of creating these
mechanical bioreactors to understand the role of mechanical stimulation in tissue
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engineering27,30-37. These effects from the stimulation are most likely specific to each cell
type and biomaterial scaffold combination used. Overall, tissue engineering is a complex
and specific method to regenerate tissues. The complexity increases when multiple tissue
types being engineered, such as the enthesis. With the right combination of scaffolds,
cells, and signals, the body can be directed to regenerate the functional interface.
Hypothesis
The purpose of this research to explore a combination of biomaterial scaffolds,
cell types, and ECM signals with tissue engineering techniques to aid in the repair of
tendon-to-bone interfaces of both civilians and soldiers. We hypothesize that a
commercially available scaffold can be modified with mechanically stimulated tissue
specific ECM to induce faster tissue integration than the scaffold alone to aid in repair of
the tendon-to-bone interface.
Specifically in this project, integration will be aided by modifying current
commercially available scaffolds targeted for tendon repair with tissue-specific coating of
cell deposited ECM. Distinct regions for tendon and bone will be formed on the scaffold
using fibroblasts to deposit ECM to create a tendon region and osteoblasts to deposit
ECM for the bone region. We then apply varying mechanically stimulation parameters to
condition the cells while they deposit the ECM on the scaffolds. Chapter 2 focuses on
the identification of the biomaterial scaffold from three commercially available materials.
Chapter 3 describes the development of the co-culture protocol and characterization of
co-cultured ECM coated scaffolds. Chapter 4 describes the methodology of applying
mechanical forces to the cell seeded scaffold, characterizes ECM deposition on the
scaffold and how that ECM activates tissue specific genes in MSCs.
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CHAPTER 2: SCAFFOLD CONSIDERATIONS FOR TENDON/BONE
INTERFACE ENGINEERING

INTRODUCTION
Tissue Engineering has become commonplace in biomedical research and
regenerative medicine. Tissue engineering techniques have been established to create the
paradigm consisting of combinations of scaffolds, cells, and signals1. Attempts to create
various tissues in vitro have been reported by changing the scaffold’s material, structural
and mechanical properties, the cell types seeded, or the mechanical and chemical
signals2. Often these reports have been focused on engineering single tissue types in
vitro but recently a growing focus on the tissue engineering of multiple tissue types, or
interfaces of tissues are being explored3,4. The targeted application has been on
functional repair of interfaces of musculoskeletal tissues especially at the boundary
between cartilage to bone, muscle to tendon, and tendon/ligaments to bone3,5. The work
in this study focuses on the tendon/ligament to bone interface.
The tendon to bone interface, called the enthesis, transitions from a highly
oriented non-calcified tension-based tissue to a calcified compression-based tissue in a
very short distance6-8. The body achieves this transition naturally through a direct
insertion6. Direct insertions accomplish attachment through a four layer transition from
tendon to fibrocartilage to mineralized fibrocartilage to bone7-10. Examples of a direct
insertion that are also sites of orthopedic intervention include the supraspinatus tendon of
the shoulder rotator cuff and the anterior cruciate ligament in the knee7,8. The problem
with these direct insertions for tendon to bone is that they are mostly avascular which
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make natural repair difficult7,11,12. Tendon has specialized fibroblasts, called tenocytes,
which have low metabolic activity and low healing capabilities and are used for
maintenance of tendon extracellular matrix (ECM) and not necessarily tissue
regeneration11,13. Since injuries at these interface sites do not heal well, surgery is often
the best option for repair6,7,11,12,14. Grafts are necessary to regain mechanical function for
very serious injuries7. Currently, autografts are considered the gold standard but have
complications of their own including: extra harvesting surgeries, donor site morbidity,
and increased risk of infection12,13,15,16. Allografts are also used clinically but are
associated with possible immune rejection, problems with cellular infiltration, and
incorporation into the surrounding tissues12,13,15,16. Synthetic grafts may provide an
opportunity to engineer the mechanical properties to achieve fixation and include
biologic components to aid in tissue integration.
In tissue engineering, the role of the synthetic grafts is as a biomaterial scaffold to
act as a three-dimensional structure to allow cell attachment, cell migration, expression of
cell signals, extracellular matrix (ECM) deposition and transfer of mechanical loads from
surrounding tissues13,17,18. There have been different scaffolding materials that have been
tested in vitro and in vivo to improve tendon to bone fixation. Commercially available
materials that have been used for tendon to bone repair include various braids, wovens,
and knits of non-degradable polyester terepthalate (PET), polytetraflouroethylene
(PTFE), and polypropylene (PP) and polycarbonate poly(urethaneurea)19-23. Degradable
synthetic materials that have been used include poly(urethaneurea), and polylactic acid
(PLA) 18,23,24. Commercially available biologic ECM based materials include acellular
dermal matrices from human, bovine, porcine, or equine sources23,25,26. These devices
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have been approved by the FDA because they are single biomaterials or, in the case with
dermal matrices, labeled as tissues26. Other devices which are gaining interest are
combination devices of a biomaterial with growth factors or biologic factors including
cells. These combination technologies could take up to a decade or more to gain
regulatory approval. There may be an opportunity to expedite therapeutic technology
through the FDA by modifying a commercially available graft with decellularized ECM
coatings to accommodate the mechanical and biologic needs of the tendon-to-bone
interface.
Specifically in regards to this study, integration will be aided by modifying
commercially available scaffolds targeted for tendon repair with a tissue specific coating
of cell deposited ECM. Fibroblasts will be used to deposit ECM to create a tendon
region and osteoblasts will be used to deposit ECM for the bone region. This study
focuses on single culture of both fibroblasts and osteoblasts to evaluate a non-degradable,
degradable, and biologic substrates as candidates for a tendon to bone interface scaffold.
After 28 days in culture, the scaffolds will be evaluated quantitatively and qualitatively
for mechanical properties, cell survival, and ECM deposition.
METHODS
Materials
Representative commercially available degradable, non-degradable, and biologic
scaffolds were selected for testing. Fabrics were also targeted due to the high surface
area and tensile strength inherent in the fabric structure. The non-degradable custom
fabric scaffold is polyethylene terephthalate (PET) [Biomedical structures, Warwick, RI]
and has been previously used in research in our laboratory. The degradable fabric is X-
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Repair®, a commercially available polylactic acid (PLA) woven fabric provided by
Synthasome Inc, CA. X-Repair® is currently used for surgical reinforcement for tendon
rotator cuff repair. The biologic representative is BioTape® (BT), an acellular porcine
collagen dermal matrix provided by Wright Medical Technology, TN. BioTape® is
currently used for reinforcement of tendons at suture sites after repair.
The BioTape samples come sealed in sterile packaging, so additional cleaning and
sterilization were not necessary. Care was taken to keep the BioTape sterile using aseptic
technique while preparing the samples for cell culture. The fabric scaffolds were not
provided in sterile condition so cleaning and sterilization was necessary. Fabric samples
were cut to the appropriate size based on the experiment to be performed. The edges
were fused thermally to prevent unraveling of the fabric. The fabrics were sonicated in
an ultrasonic bath in a 1% by volume triton-x 100 detergent solution to remove any
possible oils or dirt that may be present after manufacturing. The samples were well
rinsed several times in deionized water to remove any residual detergent. The fabric
samples were further soaked in 70% ethanol (EtOH) and placed under UV light for 1
hour, flipped, and repeated for another hour to sterilize the scaffolds. Samples
undergoing mechanical testing were not sterilized.
Mechanical Testing
Prior to cell culture, the scaffolds were evaluated for basic mechanical properties
and their potential load bearing capabilities. Each scaffold type (n=5) was cut to 12.5
mm width and 50 mm length. All samples were fully hydrated in phosphate buffered
saline (PBS) before loading. Scaffolds were clamped into an Instron 33R-4465 load
frame (Instron, Norwood, MA) and loaded in tension at a rate of 25mm/min until failure.
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Measurements were taken using a 500 N load cell at a sample rate of 100 Hz using
Bluehill 2 software. The PET and PLA fabrics average fiber diameter was measured
under microscopy to calculate cross sectional area. BioTape was measured directly with
digital calipers (Mitutoyo, Aurora, IL). The stress strain curve was calculated for each
test specimen. The elastic modulus, ultimate strength, and strain at failure was taken
from the stress strain curve and averaged for each scaffold type.
Cell Seeding and Culture
After sterilization, scaffolds were soaked in α-MEM (Hyclone, Waltham, MA)
containing 10% fetal bovine serum (FBS) (Hyclone, Waltham, MA) for 1 hour prior to
cell seeding. Scaffolds and tissue culture plastic (TCP) controls were seeded with NIH
3T3 mouse fibroblasts (FB) (CRL-1658 ATCC, Manassas, VA) or MC 3T3-E1 mouse
calvarial osteoblasts (OB) (CRL-2593 ATCC, Manassas, VA) in single culture. The
scaffolds were seeded at a density of 1x105 cells/mm2 in 24 well plates. Cells were
allowed to proliferate for 5 days to allow cells to migrate over the fabric and BioTape.
Day 5 is considered time zero, then samples were analyzed at days 1, 7, 14, 21, 28
afterwards. At each time point, each scaffold group type had an n=4. All seeded
scaffolds were grown in α-MEM containing 10% FBS + 1000 U/mL penicillin, 1000
μg/mL streptomycin, 2.5 μg/mL amphotericin-B (Gibco, Grand Island, NY). At every
medium change, ascorbic acid was freshly added to a concentration of 25 μg/mL.
SEM Imaging and Live/Dead Staining
The scaffolds were characterized using scanning electron microscopy (SEM).
Each scaffold type was imaged with and without cell seeding. Scaffolds were also
imaged for cell viability over the course of cell culture. Both fabric types and TCP were
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imaged using Live/Dead fluorescent stain (Invitrogen, Grand Island, NY) at days 1, 7, 14,
21, and 28 for each cell type.
Matrix Digestion
At each time point, samples were removed from the 24 well plate and placed in a
2 mL microcentrifuge tube. Then 1 mL of a buffered enzymatic digestion solution of 100
μg/mL proteinase-K (Promega, Madison, WI) was added to each sample. All samples
were then placed in an oven at 60°C overnight. The following day
phenylmethanesulfonylfluoride was added to a final concentration of 5mM to inhibit
proteinase-K. All samples were homogenized using a sonic dismembrator (Fisher
Scientific, Waltham, MA) and aliquots were taken from each sample to perform DNA,
GAG, and hydroxyproline (HYP) assays. Volumes were carefully recorded and
monitored for normalization during analysis.
DNA Analysis (Pico Green Assay)
DNA was analyzed using a picogreen assay (Invitrogen, Grand Island, NY) which
tests for double stranded DNA and was used as a normalization parameter for the other
matrix components. Aliquots of 20 μL were used and the assay was performed according
to the manufacturer’s instructions.
Glycosaminoglycan (GAG) Analysis (Alcian Blue)
GAG content was quantified using an alcian blue (National Diagnostics, Atlanta,
GA) precipitation reaction 16,27,28. This assay takes advantage of the precipitates formed
from the binding of alcian blue to sulfated GAGs. The precipitates are centrifuged and
rinsed, then dispersed to read with a spectrophotometer. Briefly, 300 μL aliquots of
every sample and the chondroitin sulfate standards were incubated for 2 hours with 500
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μL of 25mM buffered alcian blue solution. Samples were centrifuged for 5 minutes at
16,000xg to form a pellet and aspirated. Pellets were then rinsed with 40% EtOH/buffer
solution and recentrifuged for 5 minutes at 16,000xg. The supernatants were aspirated
and 500 μL of 10% SDS in water was added to resuspend the pellet. Samples were
resuspended using the sonic dismembrator. The resuspended solutions were transferred
to a 96 well plate and read on a spectrophotometer (Molecular Devices, Sunnyvale, CA)
at a wavelength of 620 nm.
Collagen Analysis (Hydroxyproline assay)
Collagen content was quantified by direct measurement of the amino acid,
hydroxyproline 29,30. Collagen proteins are hydrolyzed to amino acids using 6M HCl,
amino acids are oxidized to a pyrrole with chloramine-T, and a chromophore is formed
using Ehrlich’s reagent. Briefly, aliquots were taken from each sample and the volumes
were recorded. The aliquots were mixed with 1 mL 6M HCl and placed in an oven at
100°C overnight. The solutions were then transferred to 25 mL Wheaton vials and 5 mL
deionized (DI) water was added. Samples were frozen, lyophilized, re-hydrated with 5
mL DI water, frozen and lyophilized a second time to remove the acid. Samples were
rehydrated in 1 mL DI water and aliquots were reacted with chloramine-T solution for 20
minutes at room temperature. Then Ehrlich’s reagent, 4-(dimethylamino) benzaldehyde
dissolved in 2:1 n-propanol: perchloric acid, was added to each sample and reacted for 20
minutes at 60°C to induce a colorimetric response. Absorbance was measured at a
wavelength of 550 nm.
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BioTape Considerations
The third scaffold type is BioTape and it has been segregated from the other
scaffolds simply because its characterization and response in cell culture was much
different than the other scaffolds. The first difference encountered with BioTape is that
the major determinant we used to evaluate a successful scaffold is deposition of
extracellular matrix onto the scaffolds surface. BioTape is already comprised of a dense
network of dermal matrix which consists of collagen and GAGs plus many other matrix
proteins26. Control standard samples (n=12) were dried thoroughly, weighed, and kept in
sterile PBS for the duration of the 4 week study without cell seeding. After the study,
these standards were assayed for DNA, GAG, and HYP. These amounts were then
averaged and used to subtract the baseline ECM content from the BioTape samples to
determine the amount of newly deposited ECM.
Statistics
The data for each test were collected and averaged. BioTape was normalized to
its pre-study weight. The non-cultured BioTape controls were used to subtract the ECM
contribution from the BioTape away from the ECM deposited by the cells. Both the
GAG and HYP data for each scaffold was normalized to DNA and error was propagated
due to normalization. One-way ANOVA with Student-Newman-Kuels (SNK) post- hoc
tests were performed on the mechanical testing and BioTape data, and all other data were
analyzed using a two-way ANOVA with SNK post-hoc test.
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RESULTS
Mechanical Testing
Table 1 shows the mechanical performance of each hydrated scaffold type. All
groups are significantly different from each other in maximum load, elastic modulus,
ultimate strength, and strain at failure. Compared to the other scaffolds, the nondegradable PET fabric has the highest elastic modulus at nearly 2 GPa and ultimate
strength of 326 MPa but also has the lowest load until failure at 78 N due to the smallest
amount of material contributing to loading. The degradable PLA scaffold has a larger
cross-sectional area than the PET and accommodated the highest loads of the three
scaffolds tested. The PLA also had an elastic modulus of 1.35 GPa and an ultimate
tensile strength of 301 MPa, significantly less than the PET. The hydrated biologic
BioTape scaffold had the highest cross-sectional area of the scaffolds and at 144 N,
accommodated almost double the loading of the PET scaffold. However, once
calculated, the elastic modulus of the BioTape was two orders of magnitude lower than
the other scaffolds at 38 MPa and the ultimate tensile strength was an order of magnitude
lower at 12 MPa. The strain at failure of the non-degradable PET was significantly lower
than the degradable PLA at and the BioTape scaffolds.
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TABLE I. Tensile testing of each scaffold type.
Scaffold

Maximum
Load (N)

Cross sectional
Area (mm2)

Ultimate
Strength
(MPa)
326 ± 18*

Strain at
Failure (%)

0.24

Elastic
Modulus
(MPa)
2055 ± 118*

PET

78.3 ± 4.3*

PLA

240.6 ± 17.7*

0.80

1353 ± 26*

301 ± 22*

38 ± 34

25 ± 3*

BT
144.7 ± 18.2*
12.25
38 ± 7*
12 ± 2*
40 ± 3
Data are presented as means ± standard deviations. *Within columns, groups are
statistically different from the other groups, p < 0.01. PET = polyester fabric, PLA =
polylactic acid fabric, BT = BioTape acellular porcine matrix. Statistics were not
performed on cross sectional area.

SEM
Scanning electron microscopy was performed to show topographical differences
between scaffold types. Each cell seeded scaffold is presented in Figure 1, with ECM
deposition early in the growth study. All scaffolds supported cells and matrix deposition
was noted on all scaffolds after culture at 4 days. The surfaces of the fibers in both
fabrics are smooth with little surface roughness. This morphology did not hinder cell
attachment or ECM deposition. The BioTape was more difficult to assess new ECM
deposition, as it is already ECM based, however at higher magnification seeded cells
were observed. Figure 1 shows comparisons of seeded and non-seeded PLA scaffolds (A
& D). Image E shows a cell sheet that became detached from the underlying PET fabric
during the dehydration and coating step. Images C and F show BioTape with cells at
100x magnification (C) and with no cell seeding at 75 x magnification (F). The surface
appears to have a smoother surface after cell seeding.

17

FIGURE 1. SEM images of three scaffold types at 4 days. Early ECM deposition is
visible on each seeded scaffold. (A) PLA Fabric with cells – 75x magnification, (B) PET
Fabric with cells – 100x magnification, (C) BioTape with cells – 100x magnification, (D)
PLA fabric without cells – 75x magnification, (E) PET fabric with a detached cell sheet
exposing the fabric underneath – 100x magnification, (F) BioTape without cells – 75x
magnification.

Live Dead Staining
Images from Live/Dead imaging of the cells seeded on substrates are shown in
Figure 2. Cells proliferated and deposited matrix on the scaffolds over the course of 28
days. At each subsequent seven-day time point, the images appeared to become
increasingly blurry. It is hypothesized the lack of focus is due to continuous ECM
deposition that diffuses the light. It is also difficult to acquire a high magnification image
of the cells on fibers because none of the scaffolds provide a flat surface. The fabrics
have multiple focal planes between the interweaving fibers. As seen in Figure 3, once a
focal plane is selected the fibers are translucent which further diffuses the fluorescence of
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the cells. Even though the fibers seem to autofluoresce, they do not. Therefore, the best
qualitative data were observed from 4x magnification images. Cells proliferated and
viability remained high for the length of the study.
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FIGURE 2. Series of Live/Dead Images on TCP, PET, PLA with FB. Images were
recorded over the 28 day study. All magnifications are 4x. Scale bar in every image is
500 microns. Cells were seeded at 1x105 cells/mm2. Cells proliferated until confluence.
Cell viability remained high over the course of the study.
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FIGURE 3. Live Dead image of FB on PLA fabric at Day 7 - 10x magnification. This
image demonstrates the multiple focal planes due to the fabric surface as well as the
fluorescence of the cells observed through the translucent fibers. The vast majority of
cells were live (green) while few dead cells (red) were observed.

DNA (Picogreen assay)
The DNA data used for normalization are presented in Figure 4. Both fabric
types supported cells but not to the level of the tissue culture plastic control. DNA was
present on both scaffolds and TCP over the entire 28 day study. Only the FB had
significantly higher DNA values for the PLA over the PET scaffold for days 7, 14, and
28. There were approximately equal amounts of DNA regardless of cell type indicating
the scaffolds were equally supportive of the cells.
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FIGURE 4. DNA data [means ± standard deviations] from OB (A) and FB (B) cultured
on PLA and PET scaffolds and a TCP control (BioTape is presented separately). With
respect to the OB, the TCP control was significantly greater than the scaffolds. There
was no difference in scaffolds. For the FB, The TCP was also significantly greater than
the scaffolds. On days 7, 14, and 28 the PLA scaffold had significantly more DNA than
the PET scaffold. *p<0.05.

GAG (alcian blue assay)
Using the alcian blue method, deposited GAG amounts were quantified and
normalized to DNA. Figure 5 shows that both scaffold types promoted significantly
more GAG/DNA than the TCP control for both cell types at most time points. There was
no significant difference between PLA and PET scaffolds for OB. On day 1 PLA fabric
had significantly more GAG/DNA than the PET scaffolds, however by day 28 PET had
significantly more deposition per cell. Day 1 was observed to have a high GAG per cell
amount when compared with the other time points. This is most likely due to the lower
DNA amounts on the scaffolds at day 1, so that any GAG present will be amplified. For
the remaining time points, GAG per cell tended to remain constant for the osteoblasts or
increase slightly for the fibroblasts.
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FIGURE 5. GAG data [means ± standard deviations ] normalized to DNA for PLA and
PET scaffolds and a TCP control for both OB (A) and FB (B). Both scaffolds had
significantly more GAG/ DNA than the TCP control for most time points. There was no
significant difference between PLA and PET scaffolds for the OB. PLA supported
significantly more GAG/DNA than the PET scaffold on days 1 but the PET scaffold had
higher amounts on day 28 for the FB. *p<0.05.

Hydroxyproline Content
Collagen content of deposited ECM was measured using the hydroxyproline
assay. Figure 6 shows normalized HYP/DNA amounts for each type on the scaffolds
(BioTape is presented separately). For the osteoblasts, with exception of the PET
scaffold on day 1, there was no significant difference of HYP/DNA for any of the other
scaffolds on any time point. With respect to the fibroblasts, the PET scaffold did support
significantly more HYP/DNA than the PLA scaffold or TCP control. As seen previously
with the GAG/DNA data, day 1 was observed to have a high HYP/DNA amount due to
the lower initial cell numbers on the scaffolds making any deposited hydroxyproline
seem higher. For the remaining time points, HYP/DNA tended to slightly increase
especially for fibroblasts on the PET scaffolds.
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FIGURE 6 – Hydroxyproline data [means ± standard deviations] normalized to DNA for
PLA and PET scaffolds and a TCP control for both OB (A) and FB (B). For the OB, the
PET fabric had significantly higher collagen content per cell on Day 1. For the FB, the
PET fabric had significantly higher collagen per cell on day 1, 14, 21 and 28. There was
no difference between the PLA scaffold and TCP control. *p<0.05.

BioTape
As mentioned previously, BioTape is an ECM based biologic scaffold comprised
of the same ECM components assayed for in this study. Therefore, all data presented in
Figure 7 have been normalized to the 12 standard samples without cell seeding in order to
subtract out the baseline BioTape signal. The signal measured from the BioTape
standards was much higher than the signal detected from the samples with cell deposited
ECM. Another complication with normalizing to non-seeded acellular BioTape
standards was that large amounts of DNA were extracted from the BioTape. This
suggests that the DNA is not completely removed from the BioTape matrix25,26 which
further complicates DNA normalization for the GAG and collagen assays. Once
normalized to the BioTape standards, most of the data was near zero or negative. DNA
measurements of seeded scaffolds increased over the course of the study for both cell
types indicating cell proliferation after seeding. Both GAG and HYP amounts measured
decreased over the duration of the study. Once normalized to DNA and the BioTape
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baseline, the GAG and HYP amounts had steadily decreasing values. There was a
significant difference from day 1 to days 21 and 28 for the GAG/DNA for both cell types.
There was no significant change in HYP/DNA for either cell type over the 28 days.

FIGURE 7 – Both normalized GAG and HYP data [means ± standard deviations] for the
BioTape scaffolds. (A) GAG/DNA for OB. There was a significant decrease from day 1
to days 21 and 28. (B) GAG/DNA for FB. There was no difference between days 1, 7
and 14. However, there was a significant decrease with days 21 and 28. (C) HYP/DNA
for OB. There was not a significant decrease in HYP/DNA. (D) HYP/DNA for FB.
There was no significant decrease in HYP/DNA. *p<0.05.

DISCUSSION
The purpose of this study was to determine an appropriate biomaterial scaffold for
tissue engineering of the tendon to bone interface for future evaluations. The scaffold
options were commercially available candidates chosen to compare characteristics of a
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non-degradable, degradable and a biologic biomaterial. The overall function of tissue
engineering scaffolds is to allow cell attachment, cell migration, expression of cell
signals, extracellular matrix (ECM) deposition and transfer of mechanical loads from
surrounding tissues5,31. As biomaterials, all three scaffolds allowed for cell attachment,
proliferation and had good cell viability with fibroblasts and osteoblasts based on SEM
and Live/Dead imaging. For use in tendon to bone interfaces, the scaffolds need to
combine the properties of tendon and bone tissue-engineering scaffolds into a single
construct. This means balancing mechanical properties and biologic responses of the
scaffold. The main cause of graft failure is insufficient functional integration with the
surrounding tissue to achieve mechanical stability at the interface16. In the past, PET
scaffolds were used in ligament repair with limited success20-22. Scaffolds showed good
initial fixation and results but long-term the implants loosened at the surgical site and did
not provide stability. PET was included in this study because modifying the nondegradable with a biologic coating may help bridge the mechanical benefits of synthetic
biomaterials biologic with the benefits of ECM based biomaterials.
The representative ECM components selected to determine cell based ECM
deposition on the scaffolds were glycosaminoglycans and collagen. GAGs are important
matrix components for stabilizing ECM and collagen fibrils in connective tissues, bind
water to create hydrostatic pressure, and show general matrix deposition32. Chondroitin
sulfate is the most prevalent GAG in bone and is also present in tendon. GAGs
participate in other tendon important proteoglycans, such as decorin and biglycan, which
act as crosslinkers for collagen aiding in an increase of tensile strength 33. The assay we
performed, alcian blue, is used in a precipitation reaction with sulfated GAGs to allow for
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quantification 27,28. This reaction binds to all sulfated GAGs, but not to non-sulfated
GAGs. For the purposes of this study it was not necessary to determine the specificity of
individual GAGs, since sulfated GAGs are present in both bone and tendon ECM32. In
our studies, once the GAG data were normalized to DNA, both of the fabric scaffolds had
higher GAG deposition per cell compared to the TCP control. This may be due to the 3D nature of the scaffolds that has higher surface area for the cells, rather than forming a
monolayer sheet on the TCP. Both cell types deposited significantly more GAG on the
PET and PLA scaffolds compared to TCP control. We also found that after the initial
GAG deposition on the scaffolds, the OB deposited GAG per cell leveled off while the
FB deposited GAG per cell increased over the study. A study by Visser et al. using the
same PLA fabric with primary tenocytes showed that total sulfated GAG amount
remained unchanged with time18.
The other ECM component measured was collagen. It is the major component
found in connective tissues, especially bone and tendon 3,10,33. Hydroxyproline comprises
10.8% of the amino acids in collagen29,30 and is relatively specific to collagen. However,
this assay does not distinguish between collagen sub types, such as collagen I, II, and III,
all of which are found in different parts of the enthesis. Also while hydroxyproline is
mostly seen in collagens, it is also 1% of the amino acids found in elastin, another matrix
component in tendon13. Elastin exists as less than 3% of the ECM content in tendon3 so
it was not a concern for measuring potential small amounts of elastin-contributing
hydroxyproline along with the major contributing collagen based hydroxyproline. There
were not as many differences between scaffolds for collagen deposition. The fibroblasts
did deposit significantly more collagen per cell on the PET fabric than the other
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scaffolds. It is possible, there may have been some acidic by products34 or small amounts
of degradation of the PLA over the 4 week study causing less accumulated amounts of
collagen compared to the non-degradable PET fabric13. Further testing is needed to
confirm this hypothesis. A continuous deposition of collagen on the PLA fabric over 28
days was also reported by Visser, et al18. Hydroxyproline is a good first step and
selection assay for the differing scaffold types. In future studies, more specific collagen
subtypes can be studied to distinguish between tendon, bone, and the fibrocartilage
transition zone.
ECM accommodation is just one factor in the scaffold selection criteria.
Mechanical stability is another major factor in whether a scaffold can be a successful
graft. The primary cause of graft failure occurs because of mechanical stability at the
interface junction and lack of functional intergration16. This is one reason why synthetic
grafts have been so attractive as scaffolds because the mechanical properties can be
tailored to suit the needs of the tissue being engineered 12. The mechanical strength of
the scaffolds was measured through tensile testing, since tendons are primarily under
tensile loads. Depending on which tendon is tested and which methods of testing are
used, tendon can have a range of mechanical values. The elastic modulus of tendon
typically ranges between 500-1850 MPa, strains at failure are between 50-125 MPa, and
failure strains are 13-32% for bone-tendon-bone specimens or 5-16% for tendon proper35.
The PET scaffold in comparison has an elastic modulus and ultimate strength that are
greater than native tendon and a failure strain within the range of a bone-tendon
specimen. Similarly, the PLA scaffold has an elastic modulus that falls within the range
of native tendon and a higher ultimate tensile strength and higher strain at failure than
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tendon. It is promising that if a suitable fixation method could be attained then the
mechanical properties of the scaffolds could accommodate loading until tissue integration
is achieved. The biologic scaffold had a mechanical performance significantly lower
than the other tested scaffolds. Biologic based scaffolds, such as acellular dermal grafts
and small intestine submucosa, have not been able to establish mechanical properties
equal to native tissues, and typically have more than an order of magnitude less than
tendon25,26. Our mechanical testing concurred with these previous findings. It should be
noted that, as a commercial product, these products, including BioTape, are not designed
nor indicated for direct loading of tendon, but rather as an augmented wrap around
tendon sutures to reinforce healing25,26,36. The aim of this project, however, is to select a
scaffold that can assist in transferring some of the mechanical loading after repair during
healing.
BioTape also had several other in vitro complications associated with analyzing
the newly deposited or cell mediated ECM because of the high amounts of the baseline
BioTape ECM. Another complication is the residual DNA found in the BioTape
standards which complicates normalization of the ECM components. Other researchers
have found that ECM based materials have varying successes of removing cells, cell
components, and DNA from the ECM 13,25,26. The third unexpected result is that over the
course of the 28 day study, with no noticeable breakdown of the BioTape, the ECM
components that were quantified in the BioTape decreased. It is possible that the cells
could begin a remodeling type behavior by excreting MMPs in the form of collagenases
to breakdown the matrix or to migrate through the tissue37-39, but further evaluations
would need to be performed to confirm this hypothesis. While studies using BioTape
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have reported good in vivo performance25,26, its effectiveness as an in vitro tendon to
bone scaffold was obscured because of the negative measured ECM values, and high
ECM baseline signal compared to the newly cell deposited ECM. There is also a high
amount of residual DNA that obscures cell quantification and normalization.
In conclusion, although BioTape is reported to perform well in clinical studies,
the scaffold was difficult to assay in vitro and did not demonstrate the mechanical
strength necessary as a directly loaded tendon scaffold. While the PET and the PLA had
significantly higher ultimate strengths than the BioTape, the PLA fabric has a modulus
within the range of reported tendon values. FB did deposit more collagen on the PET
scaffolds but based on the other cellular depositions of ECM both fabric scaffolds
performed very similarly. Degradable scaffolds do have the added advantage that allow
for replacement with host tissue as the scaffold degrades. The non-degradable scaffold
does not have that opportunity and will be implanted for the life of the patient. With
mechanical performance and the ECM deposition being similar between both scaffold
types, for our application, the degradable PLA fabric scaffold is the most appropriate
scaffold for the tendon to bone interface and future studies will expand using this
scaffold. Future studies include a more efficient cell seeding technique for scaffolds,
analyzing ECM deposition using more specific ECM components, and co-culture of
fibroblasts and osteoblasts on a single scaffold to create a more mimetic tendon-to-bone
scaffold.
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CHAPTER 3: CO-CULTURED TISSUE-SPECIFIC SCAFFOLDS FOR
TENDON/BONE INTERFACE ENGINEERING

INTRODUCTION
The tendon/ligament to bone interface, or enthesis has a complex
structure/organization to enable transfer of forces through the tendon/ligament to the
bone. The body naturally achieves force transition through a four layer gradient from
tendon to fibrocartilage to mineralized fibrocartilage to bone1-4. Examples of tissues with
an enthesis include the supraspinatus tendon of the shoulder rotator cuff and the anterior
cruciate ligament in the knee1,3. Since these enthesis locations are mostly avascular,
healing after injury is very limited and often requires surgical intervention to repair the
damage. There are a reported 30,000-75,000 cases of rotator cuff repair per year in the
United States5 and an estimated 150,000 ACL surgeries each year6. In severe injuries to
these sites a graft is necessary for repair1,6-9.
Most grafts currently used clinically for repair are autograft or allograft but each
has its own complications. Autografts have additional harvesting surgeries, donor site
morbidity, and increased risk for infection, while allografts have complications with
possible immune rejection, problems with cellular infiltration, and incorporation into the
surrounding tissue environment6,10-12. Synthetic polymeric grafts have been used to
investigate repair solutions in the ACL since the 1970s and showed good short term
success but never integrated well into the repair site and ultimately failed13-17. Current,
research using tissue engineering principles are widely reported using different
biomaterials, cell types, and growth factors18,19 . Focus has been to create different
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conditions on a single scaffold that can be specific to multiple tissue types20, such as
muscle to tendon, cartilage to bone, and tendon/ligament to bone. This strategy can be
implemented by changing the biomaterial’s chemical or physical structure, the cell source
or a growth factor signal specific to the targeted tissue, or any combination of the
above21.
Ultimately, regardless of tissue application, the scaffold will have to integrate into
the tissue to transfer the loads of the musculoskeletal tissues to regain function1.
Specifically in regards to this project, a tendon-to-bone repair scaffold will be made by
modifying current commercially available degradable scaffold targeted for tendon repair
with a tissue specific coating of co-cultured cell deposited extracellular matrix (ECM).
Fibroblasts (FB) will be used to deposit “tendon” ECM and osteoblasts (OB) will be used
to deposited “bone” ECM. In this study, we examine the formulation of co-culture
medium for both cell types with regard to protein deposition and mineralization, seeding
specificity on scaffold, and ECM characterization on the tissue specific regions of the
scaffold.
METHODS
Medium Determination
To determine the appropriate co-culture medium formulation with respect to
mineralization, NIH 3T3 mouse fibroblasts (CRL-1658 ATCC, Manassas, VA) or MC
3T3-E1 mouse calvarial osteoblasts (CRL-2593 ATCC, Manassas, VA) cells were seeded
on tissue culture plastic (TCP) in single culture with varying concentrations of betaglycerophosphate disodium pentahydrate (β-GP) (MPbio, Santa Ana, CA) to balance
high OB mineralization with low FB mineralization. Both cell types were seeded at
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1x104 cells/cm2 per well in a 12-well plate(BD Falcon, San Jose, CA ) in α-MEM
(Hyclone, Waltham, MA) containing 10% fetal bovine serum (FBS) (Hyclone, Waltham,
MA) + 1000 U/mL penicillin, 1000 µg/mL streptomycin, 2.5 µg/mL amphotericin-B
(AB/AM) (Gibco, Grand Island, NY) and at every medium change 25 μg/mL L-ascorbic
acid (AA) (Acros Organics, NJ) was freshly added. To this formulation 0, 1, 3, or 5 mM
of β-GP was added. Medium was changed every 2-3 days. Seeded plates were cultured
in an incubator at 37 °C and 5% CO2. At timepoints of 1, 4, 7, and 14 days, medium was
removed from the plates and samples were frozen at -80 °C until the end of the study, at
which point 1 mL of biology grade water was added and all cells were lysed with an
ultrasonic dismembrator (Fisher Scientific, Waltham, MA). Aliquots were then taken to
perform picogreen assay for DNA quantification (Invitrogen, Grand Island, NY), Pierce
BCA for total protein (ThermoScientific, Rockford, IL), and calcium assay for
mineralization (Pointe Scientific, Canton, MI). All assays were performed according to
the manufacturer’s protocols. The medium determination experiment, including similar
concentrations of medium additives and data collection timepoints were based on a
similar study by Wang et al2. After the data were collected, total protein and
mineralization data were normalized to DNA. All test medium formulations with each
cell type were evaluated in triplicate at each time point.
Scaffold Seeding
The scaffold used for this study is X-Repair®, a commercially available poly-llactic acid (PLA) woven fabric provided by Synthasome Inc, CA. X-Repair® is currently
used for surgical reinforcement for tendon rotator cuff repair. PLA fabric scaffolds were
cut into strips with dimensions of 10 mm wide by 60 mm long. The edges were sealed by
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thermally fusing the polymer so the fabric structure would not unravel. The scaffolds
were cleaned with a detergent solution, rinsed thoroughly with deionized water multiple
times, and sterilized with 70% ethanol and UV light. Prior to cell seeding, the scaffolds
were soaked in sterile culture medium containing FBS overnight to aid in cell attachment.
The scaffolds were seeded with FB and OB in co-culture at a 1x106 cells/scaffold region,
as shown in Figure 1. The total number of cells per scaffold was 2x106, one million each
of FB and OB. All seeded scaffolds were grown in α-MEM containing 10% FBS +
AB/AM + 3mM β-GP and at every medium change 25 μg/mL AA was freshly added.
All seeded scaffolds were kept in an incubator at 37°C and 5% CO2.

FIGURE 1. Schematic of how the PLA scaffolds are seeded with FB and OB on coculture to make a tendon region and a bone region on the scaffold. There is a transition
zone between the two regions where both cells interact.

Cell Tracking and Migration
To track the cells’ location and migration after seeded and to confirm that tendon
and bone regions can be successfully seeded on a scaffold, the cells were labeled with
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two different fluorescent stains by a method modified by Wang et al2. FBs were labeled
with Cell Tracker Green (Lonza, Alendale, NJ) and the OB were labeled with Cell
Tracker Orange (Lonza, Alendale, NJ) according to the manufacturer’s protocols.
Briefly, cells were removed from the TCP flask, collected and centrifuged at 16,000xg
for 5 minutes to form a pellet. FBs were resuspended in a 10 mM green tracker solution
and the OB were resuspended in 10 mM orange tracker solution for 30 minutes and
placed in an incubator. Labeled cells were seeded on the scaffolds as described
previously, shown in Figure 1. The cells were allowed to attach to the scaffolds for 6
hours after seeding. The scaffolds were then placed in a sterile custom made cover glass
petri dish for fluorescence imaging. Using an inverted microscope (Nikon, Melville, NY)
and a motorized stage (ASI Imaging, Eugene, OR) the entire scaffold was imaged by
taking approximately 200 images at 4x magnification and stitching the images into a
montage using BioQuant Osteo software (BioQuant, Nashville, TN). Scaffolds were
imaged once at excitation/emission (ex/em) of 470nm/515nm then again at ex/em of
540nm/590nm. Both images were then merged together with BioQuant. Images were
replicated at 6, 18, 30, and 42 hours for cell migration.
ECM Deposition
Extracellular matrix on the scaffolds was quantified after 28 days culture to
characterize and evaluate the matrix deposited by the cells on the scaffolds. Cells were
seeded as previously described. The evaluated and selected culture medium used was αMEM containing 10% FBS + AB/AM + 3mM β-GP and 25 μg/mL AA was freshly added
at every medium change. All scaffolds were cultured individually in 100mm non-treated
polystyrene petri dishes. Scaffolds were moved to new petri dishes every 7 days to
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prevent cells that migrated off the scaffolds from becoming confluent. Scaffolds (n=4)
were collected at timepoints of 1, 7, 14, 21 and 28 days. At each timepoint, the 10 x 60
mm scaffolds were removed from the petri dish and cut into three 10 x 20 mm sections.
Each scaffold, therefore, produced a tendon section, a transition middle section, and a
bone section for analysis. Each section was placed in a 1.5 mL microcentrifuge tube and
1 mL of a buffered enzymatic digestion solution of 100 μg/mL proteinase-K (Promega,
Madison, WI) was added to every tube. All samples were then placed in an oven at 60°C
overnight to digest the ECM. The following day phenylmethanesulfonylfluoride (PMSF)
was added to a concentration of 5mM to inhibit the proteinase-K. All samples were
homogenized using a sonic dismembrator and aliquots were removed for analysis. One
aliquot was used to test for cell number through DNA quantification (Picogreen green
assay, Invitrogen, Grand Island, NY). Another aliquot was used to measure the
glycosaminoglycan (GAG) content (National Diagnostics, Atlanta, GA) through an alcian
blue precipitation reaction22,23. The last aliquot was used to quantify collagen content
through the detection of the amino acid hydroxyproline (HYP)24,25. All volumes were
carefully recorded for normalization during analysis.
Statistics
The data for each test were collected and averaged. All assays including Pierce
BCA, Calcium, GAG, and HYP were normalized to their respective picogreen DNA
assays for each respective sample. Then Two-way ANOVA with Holm-Sidak post-hoc
test was performed on the necessary groups at a significance level of α=0.05 using
SigmaStat 3.1 (Systat Software Inc., San Jose, CA).
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RESULTS
This study had three main objectives: (1) to determine a suitable medium
formulation to balance OB to FB mineralization, (2) to demonstrate successful substrate
seeding in co-culture to create multiple regions on a single scaffold, and (3) to measure
and quantify the ECM deposited across the scaffold and the difference in co-cultured
regions.
Medium Determination
In the co-culture medium formulation, two additional components were added to
the standard growth medium formulation, ascorbic acid for collagen deposition and β-GP
for mineralization. Ascorbic acid concentration was held constant for all formulations at
25 µg/mL. The amount of β-GP was varied in the co-culture medium to look at
differences in total protein expression and calcium deposition per cell by both FB and OB
in single culture. Cell number was estimated from DNA measurements. Figure 2 shows
that the FB did not differ significantly in total protein per cell regardless of β-GP
concentration. There was only a gradual increase in protein deposition between days 1
and 14. The only significant difference is between day 1 and day 14 in the 5 mM group.
The OB protein deposition was also not significantly affected by the β-GP. However,
there were some significant time dependent increases in total protein compared to day 1.
Overall, β-GP had little effect on total protein deposition which may be more strongly
attributed to the ascorbic acid 26-28.
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FIGURE 2. Average total protein deposition plus standard deviations of (A) FB and (B)
OB cultured in 0, 1, 3, or 5 mM β-GP. Each group was measured in triplicate. There was
no significant difference in FB or OB total protein deposition with regard to β-GP
concentration. There are some significant time dependent effects on protein deposition.
*indicates statistical significance of p<0.05.

There was a more observable effect of β-GP concentration on mineralization in
the OB cell line. Within days 1, 7, and 14, the 5mM β-GP concentration produced a
significantly higher amount of calcium deposition than the other concentrations. There
was also a significant time dependent increase (significance is not indicated in the OB
graph) in calcium deposition for every β-GP concentration. There was no significant
difference within each timepoint for β-GP concentration on FB mineralization. There
was, however, a significantly higher amount of FB calcium deposition on the day 14
timepoint compared the other days, with the exception of the 3mM β-GP group. Due to
the low fibroblast mineralization to osteoblast mineralization, the 3 mM β-GP
concentration was used in medium formulations for the subsequent studies.
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FIGURE 3. Average calcium deposition plus standard deviations of (A) FB and (B) OB
cultured in 0, 1, 3, or 5 mM β-GP. Each group was measured in triplicate. There was not
a significant difference between β-GP concentrations in FB mineralization. There was a
significant time dependent increase in Day 14 compared to other days. For OBs, there
was a significant increase in mineralization of the 5mM concentration for each time point
compared to the other concentrations. There was also a significant increase in
mineralization for all concentrations over time (not indicated on graph). *indicates
statistical significance of p<0.05.

Fluorescence Imaging of Scaffold Seeding
The second objective of this study was to investigate seeding a single scaffold in
co-culture to create tendon- and bone- specific regions. The FBs were stained with green
tracking probe and the OBs were labeled with a red tracking probe. The montage image
in Figure 4 shows the entire 10 mm by 60 mm scaffold first with the green filter enabled
then with the red filter. Each montage is comprised of approximately 200 individual 4x
magnification images taken with the aid of a motorized stage and stitched together using
BioQuant software. As can be seen in Figure 4, both FB and OB are attached on their
respective half of the scaffold creating the tissue specific regions. The general tissue
specific regions at low magnification are easier to distinguish. Figure 5 contains the two
non-merged images with smaller selected regions shown at higher magnifications. There
are very few FB in the OB region and vice versa. On the left hand edge of the OB side,
FB did attach and is more evident at higher exposure times. However, most cells are
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located in their respective regions with a decreasing gradient across the scaffold. There
was no noticeable migration of cells between regions observed over the 42 hours in
Figure 6. The fluorescence label loses intensity over time, and therefore, the exposure
time was increased by the 42 hour image to intensify the colors on the scaffold. Because
of the increased exposure, the 42 hour image has a noticeable amount of unanticipated
autofluorescence in the periphery of the image. This is due to the cyanoacrylate used to
make the custom glass cover slip petri dish for imaging and not the FB fluorescing.

FIGURE 4. Fluorescent labeled FB (Green) and OB (Red) on the PLA scaffold form
distinct tissue specific regions at 6 hours. The two images using the cell tracker green
and cell tracker orange probes separately were merged to show how the cells are seeded
on the over entire scaffold. Image consists of approximately 200 images at 4x
magnification stitched together. Scaffold size is 10 mm wide by 60 mm long.
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FIGURE 5. Image A and B The same two images seen from Figure 4 with higher
magnification selections shown. Images C, D, and E show FB in the bone, transition, and
tendon regions, respectively. Images F, G, and H show OB in the bone, transition, and
tendon regions, respectively.
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FIGURE 6. Merged fluorescent images over a 42 hour period. Images show that the
cells maintain the tissue specific regions on the scaffold. No noticeable migration was
observed in the measured time frame. There are green labeled FB in the bone region and
red labeled OB in the tendon region even though no major cell migration was observed.

ECM Deposition
The last objective of this study was to quantify the basic components of the ECM
deposited on the static scaffolds in the tendon, bone, and transition regions. These
components are GAGs and collagen measured by alcian blue and hydroxyproline,
respectively. Deposited matrix distribution among the different regions the scaffold was
measured by analyzing equal thirds of the scaffold, creating a tendon, transition, and bone
specimen per scaffold. The DNA quantified in Figure 7, indicated no significant
differences between particular sections representing uniform cell dispersal over the
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scaffold, including the transition section. A significant time- dependent difference
between day 1 and the other timepoints was found. DNA was used to normalize the
GAG and HYP data. GAG/DNA measurement was significantly higher in the tendon
region compared to the other regions on day 14 and day 28. No significant collagen
deposition difference between scaffold regions was determined in these static conditions.
A continual and significantly increasing deposition of collagen over the entire 28 day
study was found. This indicates good cell viability and activity on the scaffold. Even
though not statistically significant, an interesting observation was that the ECM detected
in the transition region had intermediate values in between the bone and tendon regions
and would suggest mixed contributions from each cell type on the scaffold.
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FIGURE 7. Quantification of DNA, GAG, and HYP deposition on the co-cultured
scaffolds. The scaffolds were sectioned into equal thirds and analyzed separately. All
data are mean values plus standard deviations. Groups were tested with n=4 replicates.
(A) DNA amounts were not significantly different between the scaffolds regions but it
did significantly increase from day 1 then stay relatively constant. (B) There was a
significantly higher deposition for GAG/DNA in the tendon region compared to the bone
region for day 14 and 28, with the transition region having intermediate values between
the two. (C) There were no significant differences between groups for HYP/DNA
deposition but there was significantly increasing collagen content over time. Continually
increasing collagen deposition is indicative of active and viable cells on the scaffold, in
this co-culture model. *indicates statistical significance of p<0.05.
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DISCUSSION
The ultimate goal of this research was to create a more effective tissue engineered
scaffold for tendon to bone interfaces that will integrate with the host tissue, provide
functional aid while healing, and then degrade overtime as the host tissue replaces the
scaffold. The approach taken to achieve this goal was to create a tendon specific and a
bone specific region on a scaffold using cell deposited ECM on a degradable PLA fabric
scaffold. For the tendon region fibroblasts were used and for the bone region osteoblasts
were cultured on the scaffold. In this study specifically, a co-culture compatible medium
formulation was determined, the PLA fabric scaffold can be seeded in a way to create
two different tissue-specific regions on the scaffold, and deposited ECM in each specific
region including a transition zone was quantified.
Other studies have taken similar approaches to repair of musculoskeletal
interfaces. Synthetic degradable polymers and ECM components are common scaffold
choices for tendon/ligament tissue engineering due to control of factors such as
mechanical properties, pore sizes, degradation properties, and scaffold geometry6,21,29-32.
For example, to have soft tissue ingrowth into a scaffold a minimum pore size of 200 µm
has been suggested, while calcified tissue needs a minimum of 100 µm. Another
approach to engineering interfaces is changing the cell type involved with the scaffold.
Osteoblasts are common for bone tissue engineering and specialized tendon fibroblasts,
called tenocytes, have been used for tendon. Tenocytes deposit tendon-specific ECM,
but tenocytes also have low metabolic activity and low healing capabilities which are
used for maintenance and not necessarily regeneration9,11. Therefore, other fibroblasts,
including dermal fibroblasts, have been investigated as well 33. After choosing individual

49

cell types for the appropriate ECM deposition, introducing the cells into a co-culture
environment could modify the ECM deposition compared to a single culture. In one
published study by Wang et al., they looked at how osteoblasts and fibroblasts interact in
a co-culture system for a ligament to bone interface, including preliminary experiments to
determine medium composition and ECM deposition of the co-cultured multiphase setup2 similar to our studies.
The medium formulation of Wang et al., found that 1mM β-GP was optimal for
low fibroblast mineralization and retained osteoblast mineralization at 7 or 14 days2. We
found that 3mM β-GP provided low fibroblast to osteoblast mineralization. This
response is most likely cell line specific. In their study primary bovine cells were used2,
in comparison, we used well characterized mouse cell lines, NIH 3T3 and MC 3T326.
The co-culture medium should be tuned to each unique tissue engineering system because
ECM and mineralization deposition could have impacts on scaffold integration with
tissues. For this application, the osteoblast seeded bone region was targeted for higher
mineralization than the fibroblast seeded tendon region. It was hypothesized that the
higher mineral content on the bone side would help provide an environment for
anchoring the scaffold in the bone. This approach is a common technique for bone tissue
engineering which uses minerals like di- and tri-calcium phosphates, or hydroxyapatites
to signal osteointegration34,35.

Conversely, a low mineralized tendon region is also a

functional need. Native tendon is fibrous and non-calcified lending to predominantly
tensile loading while bone being highly calcified acts mostly in compression 36.
Conditioning each region properly could help achieve functional loading earlier after
implantation.
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Mineralization is not the only important component to the tendon-to-bone
junction; subtle changes in ECM composition, like elastin, collagens, proteoglycans, and
GAGs also play a role. It was observed that the deposition of ECM transition zone on
our PLA scaffold had average values that were in between the bone region and tendon
regions values with respect to GAG and collagen. This finding would indicate that the
ECM deposition in the center of the scaffold is a mix of osteoblast and fibroblast
expression. These initial findings in validating this ECM deposition approach have
shown promise in establishing tissue specific regions with a small transition. In future
studies planned identification of more specific changes with respect to tendon-specific
and bone-specific ECM deposition will be investigated. Other reported tendon/ligament
bone studies have shown how a fibroblast and osteoblast co-cultured scaffold can form
transitions with characteristics of native tissue between regions. Wang et al. showed that
in a co-cultured fibroblast and osteoblast environment an increased collagen type II
ECM, representative of a cartilaginous zone, was deposited without the presence of
cartilage forming cells2. Their approach was taken a step further to include chondrocytes.
Several successive studies by Spalazzi et al, using degradable multiphasic scaffolds with
controlled porosity and a tri-culture of fibroblasts, chondrocytes, and osteoblasts
measured interface specific ECM components in vitro and in vivo to understand the role
of multiple tissue types in a single scaffold12,37,38. They have demonstrated the ECM of
the ligament, fibrocartilage, and bone regions found at the enthesis can be partially
recreated with in vitro culture. While no functional mechanical data of the tri-phasic
scaffolds were reported these experiments are valuable to understanding how cells can
interact spatially to produce ECM of the enthesis. In contrast, Ma et al, proposes that
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because neo-tissue genesis in a tissue engineering process is not exactly the same as
developmental or wound healing, it is likely unnecessary and impractical for a tissue
engineered scaffold to completely duplicate the ECM29. Therefore, an effective therapy
may not need to fully recreate the tendon, fibrocartilage, and bone ECM in vitro, but
deposit sufficient specific ECM to direct tissue integration in vivo. The production of a
functional repair of the enthesis may need to gain short-term mechanical stability of the
scaffold in order to initiate mechanical loading while the long-term integration of the
scaffold is directed by signaling of the tendon-specific and bone-specific ECM coatings.
A reported study by Encalada-Diaz et al. suggests in the rotator cuff a short-term stability
with long-term integration may be the case39.
Previous studies with non-degradable fabric PET scaffolds showed very good
short term results in ACL repair, but were not able to achieve long-term integration with
the surrounding tissues13-17. Applying a tissue-specific ECM coating may help bridge the
gap between the short-term success of polymer grafts and the long-term integration of
biologic materials17,40. For example Recently Li et al., has modified PET ligament
scaffolds with bioglass and hydroxyapatite to try and increase osseointegration of the
scaffold into the bone41. They performed an in vivo bone tunnel study for 2 weeks and
showed evidence of initial scaffold integration; however, long-term integration was not
evaluated in their study. The degradable X-repair PLA scaffold used in our studies
potentially has an additional advantage over a non-degradable scaffold of slowly
resorbing over a long-term period while still having short-term mechanical stability
necessary for some functional loading. The tissue-specific ECM coatings deposited on
the PLA scaffold may help integration with the surrounding tissues for successful long-
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term integration. Eventual investigation with a functional animal model will be
necessary to fully address this hypothesis.
In conclusion, the steps taken in this study have aimed to create a cell specific
extracellular matrix environment on a mechanically robust degradable scaffold to enable
better fixation of tendinous soft tissues at bony interfaces. The outlined approach is to
produce tissue-preferred areas on a scaffold to target the native tissues to integrate with
the scaffold. The scaffold will then assist with mechanical loading while the co-cultured
ECM aids the bodies healing to remodel the wound. To achieve this goal, we have
selected a suitable co-culture medium formulation for our initial work with the enthesis
scaffold. We were able to seed the scaffold in co-culture to create two distinct tissue
specific regions on the scaffold. Lastly, we measured ECM deposition on three regions
of the scaffold. Our future work is to increase the specificity of the ECM coating through
mechanical stimulation of the cell seeded scaffolds while depositing ECM and perform
more specific ECM analysis.
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CHAPTER 4: MECHANICALLY-STIMULATED CO-CULTURED TISSUESPECIFIC SCAFFOLDS FOR TENDON/BONE INTERFACE ENGINEERING

INTRODUCTION
The tendon/ligament to bone interface, or enthesis, is a complex transition that is
essential for functional motion as the interface enables the transfer of loads through the
musculoskeletal system. The musculoskeletal enthesis is a continuous transition from
tendon to fibrocartilage to mineralized fibrocartilage to bone1-4 as observed at the
supraspinatus tendon of the shoulder rotator cuff and the anterior cruciate ligament in the
knee1,3. These sites are considered avascular, limiting the healing after injury and often
requiring surgery for functional repair1,5,6. Tissue engineering is a mix of biomaterials,
cells, and biologic signals that can offer a solution for enthesis repair7-9. However,
studies have shown that specific minutiae in selecting the tissue engineering factors can
have impacts on the how the tissues are regenerated10,11. For example, increasing the
pore size greater than 150 microns will allow bone tissues to form in the biomaterial and
tendon tissues require pore sizes greater the 250 microns to form5. Different cells types
like fibroblasts, osteoblasts, or chondrocytes deposit their own extracellular matrix
(ECM) components differing in collagen types and amounts 12-14. Finally, the effects of
combinations of growth factors and cytokine signaling can be powerful determinants of
the tissue type formed in vivo. For example, bone morphogenetic protein-2 (BMP-2) can
induce bone formation in a muscle pouch where bone is not naturally found15. These
types of growth factors and signals can be useful tools for tissue engineering.
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One signaling tool for tissue formation that is commonly overlooked is
mechanical stimulation. The classic example of how mechanical forces can affect tissues
is Wolff’s law in bone16. Essentially, bone will remodel according to the forces acting
upon the bone, so increases in cyclic forces will cause cells to produce more bone and
decreases in stimulation will lead to bone resorption. There is a similar response in
tendon and other soft tissues such as muscle where an increase in use will lead to an
increase in mass and ultimate strength while a decrease in use will lead to a decrease in
mass and tensile strength17 . Techniques of applying mechanical stimulation to tissues
have been used in muscle and cardiac tissue engineering18,19. To apply these mechanical
strains, systems need to be developed to accurately control the forces applied, strain rates,
number of cycles, temperature, and gas and nutrient exchange while remaining sterile18.
How these parameters are actually controlled varies and several researchers have taken
on the challenge of creating mechanical bioreactors to understand the role of mechanical
stimulation in tissue engineering6,18-25. Results from mechanical bioreactor studies have
determined that the strains, rates, number of cycles, and resting periods can all affect the
type of ECM deposited6,18-25. These effects are most likely specific to each cell type and
biomaterial scaffold used in the mechanical bioreactor.
In this study, co-cultured tendon-to-bone scaffolds were mechanically stimulated
in a custom designed bioreactor for 35 days. It is hypothesized that cyclic mechanical
stimulation during ECM formation will increase collagen deposition and alignment on a
fabric substrate and the deposited ECM will cause an increase in tissue specific gene
markers when mesenchymal stem cells (MSCs) are exposed to the ECM. A
commercially available degradable poly-l-lactic acid (PLA) scaffold targeted for tendon
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repair was stretched over 35 days in a custom built dual strain bioreactor. Fibroblasts
were used to deposit “tendon” ECM and osteoblasts were used to deposit “bone” ECM.
Fibroblast and osteoblast deposited ECM was examined histologically and compared to
determine the effects of mechanical strain on the morphology and type of ECM produced.
Once the ECM was deposited on the scaffold, rat (MSCs) were exposed to the ECM
coating and tissue-specific gene activation was measured. The ECM of the scaffolds was
then characterized through quantitative assays and histological analysis.
METHODS
Scaffold Seeding
The tendon repair scaffold used for this study is X-Repair®, a commercially
available poly-l-lactic acid (PLA) woven fabric provided by Synthasome Inc, CA. XRepair® is currently used for surgical reinforcement for tendon rotator cuff repair. All
scaffolds in this study were seeded using the following protocol. PLA fabric scaffolds
were cut into strips with dimensions of 10 mm wide by 80 mm long. The edges were
sealed by thermally fusing the polymer so the fabric structure would not unravel. The
scaffolds were cleaned with a detergent solution, rinsed thoroughly with deionized water
multiple times, and sanitized with 70% EtOH and UV light. Prior to cell seeding, the
scaffolds were soaked in sterile culture medium containing fetal bovine serum
(formulation described below) overnight to aid in cell attachment. The scaffolds were
seeded with NIH 3T3 fibroblasts (FB) and MC 3T3 osteoblasts (OB) in co-culture at a
1x106 cells/scaffold region, shown in Figure 1. The total number of cells per scaffold is
2x106, one million each of FB and OB. All seeded scaffolds were cultured in α-MEM
(Hyclone, Waltham, MA) containing 10% fetal bovine serum (FBS) (Hyclone, Waltham,
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MA) + 1000 U/mL penicillin, 1000 μg/mL streptomycin, 2.5 μg/mL amphotericin-B
(Gibco, Grand Island, NY) + 3 mM of beta glycerophosphate(β-GP) and 25 μg/mL Lascorbic acid (AA) (Acros Organics, NJ).

All seeded scaffolds were kept in an

incubator at 37°C and 5% CO2 for 24 hours prior to placement in the bioreactor.

FIGURE 1. Schematic of how the PLA scaffolds are seeded with fibroblasts and
osteoblasts on co-culture to make a tendon region and a bone region on the scaffold.
There is a transition zone between the two regions where both cells interact.

Bioreactor and Mechanical Stimulation
After samples were seeded they were placed in the bioreactor pictured in Figure 2.
Two separate chambers were used each with 4 scaffolds per chamber. The FB side of the
scaffold was placed between the clamps labeled in Figure 2 as (A) and the OB was placed
in section (B). One chamber had the adjustable center clamp intact which stretched the
(A) FB region but not the (B) OB region (now termed FB STIM). These scaffolds were
cultured for 21 days with the middle clamp intact then the clamp was removed to allow
the cells to infiltrate the transition region to deposit ECM and the entire scaffold were
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stimulated for a further 14 days. In the second chamber the center clamp was never
utilized which allowed for the entire scaffold to be stimulated for all 35 days (termed FB
+ OB STIM). A stretching regime of 5% cyclic strain at 0.5 Hz for 1 hour per day every
day was used for the length study. The culture medium formulation was α-MEM + 10%
FBS + 1000 U/mL penicillin, 1000 μg/mL streptomycin, 2.5 μg/mL amphotericin-B + 3
mM of β-GP and biweekly 25 μg/mL AA was freshly added. Medium was completely
refreshed every 7 days. Both chambers were kept in an incubator at 37 °C and 5% CO2.
At 35 days, scaffolds were removed from the chamber and decellularized for MSC
seeding.

62

FIGURE 2. Images of the custom designed bioreactor used for the mechanical
stimulation studies. The top image shows the sterile chamber connected to the linear
actuator with gas permeable medium circulation lines attached. The bottom left image
shows a top down view of the inside of the chamber with the actuator arm connected to
the clamps that hold the scaffolds. The bottom right image shows the section labeled (A)
between the actuating clamp and the center adjustable clamp receives mechanic
stimulation and the section labeled (B) between the center adjustable clamp and the fixed
clamp does not receive stimulations. The fibroblast seeded region of the scaffold is
placed in (A) and the osteoblast seeded region is placed in (B). The entire chamber and
actuator fits inside of an incubator maintained at 37°C and 5% CO2.
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Decellularization and Mesenchymal Stem Cell Seeding
At the end of the 35 days the 10 x 80 mm scaffolds were removed from the
chambers and cut into three equal sections. Each scaffold, therefore, produced a tendon
section, a transition middle section, and a bone section for analysis. Scaffolds were
decellularized to remove any fibroblasts or osteoblasts on the scaffolds prior to MSC
seeding. The decellularization protocol was a mixture of freeze thaw, hypo- and hyperionic solutions. First samples were frozen at -80C, thawed and repeated. The samples
were alternated in solutions of deionized (DI) water for 1 hour and 10x phosphate
buffered solution (PBS) for 1 hour. This cycle was repeated for 6 cycles, placed in DI
water for one more hour, then soaked in 1x PBS for 1 hour prior to cell seeding.
Primary rat mesenchymal stem cells (MSC) were isolated from rat femurs as
previously described26. These cells were expanded then used at passage 6. MSCs were
seeded on each scaffold section at 1x106 cells per section (n=3). MSCs were also seeded
on tissue culture plastic (TCP) as a control (n=3). Samples and cells were cultured in αMEM containing 10% FBS + 1000 U/mL penicillin, 1000 μg/mL streptomycin, 2.5
μg/mL amphotericin-B (Gibco, Grand Island, NY) for 24 hours. After the 24 hour
seeding time, scaffolds sections were placed in a sterile PCR grade 1.5 mL centrifuge
tube and submerged in 0.25% trypsin with EDTA for 10 minutes to release MSCs.
Scaffolds were removed, medium containing serum was added to neutralize the trypsin,
and the tubes were centrifuged at 16,000xg for 5 minutes to form a cell pellet. All liquid
was aspirated, being careful not to disturb the pellet, then all tubes were immediately
placed in liquid nitrogen to flash freeze the samples for RNA isolation.
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RT-PCR
All PCR work was performed at the molecular resource center (MRC) at the
University of Tennessee Health Science Center (Memphis TN). RNA was isolated using
a RNeasy mini-kit (Qiagen, Hilden, DE) according the manufacturer’s protocol. RNA
quality and quantity were measured using a Qubit fluorometer (Invitrogen, Grand Island,
NY). After analysis, amplification was deemed necessary. All RNA was transcribed to
cDNA using first strand cDNA kit (Roche, Penzberg, DE). TaqMan PreAmp master mix
(Invitrogen, Grand Island, NY) was used to amplify the cDNA. Separate PCR master
mixes for each gene were then made with custom designed primers (Integrated DNA
Technologies, Coralville, IA) for Collagen III, Decorin, Osteocalcin, and Aggrecan, as
shown in Table 1. All primers were designed for rat genes and hypoxanthine-guanine
phosphoribosyltransferase (HGPRT) was selected as the best reference gene. All samples
plus master mixes were plated out and run for rt-PCR in a Light Cycler 480 (Roche
Applied Sciences, Penzberg, DE). After PCR was complete, data was analyzed for
relative changes to TCP using the delta delta Ct method27.
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Table I. PCR Primers Design
Gene
Collagen type III

Gene
Name
Col3A1

Accession
Number
NM_032085.1

Sequence
5’-tcccctggaatctgtgaatc-3’ (forward)
5’-tgagtcgaattggggagaat-3’ (reverse)

Decorin

Dcn

NM_024129.1

5’-ctccgagtggtgcagtgtt-3’ (forward)
5’-gcaatgttgtgtcaggtgga-3’ (reverse)

Osteocalcin

Bglap

M23637.1

5’-cattactgaccgctccttcc-3’ (forward)
5’-cgcatagcctgtgattttca-3’ (reverse)

Aggrecan

Acan

NM_022190.1

5’-aatgggagccagcctacaac-3’ (forward)
5’-agaggcagagggactttcg-3’ (reverse)

ECM Deposition
Extracellular matrix deposition on the scaffolds was quantified after 35 days in
the mechanical bioreactor to characterize the coating. After the MSCs were removed
from the scaffolds, each section was placed in a 1.5 mL microcentrifuge tube and 1 mL of
a buffered 100 μg/mL proteinase-K (Promega, Madison, WI) solution was added to every
tube. All samples were then placed in an oven at 60°C overnight to digest the ECM. The
following day phenylmethanesulfonylfluoride (PMSF) was added to a final concentration
of 5mM to inhibit the proteinase-K. All samples were homogenized using a sonic
dismembrator and aliquots were removed for analysis. One aliquot was used to test for
cell number through DNA quantification (Picogreen green assay, Invitrogen, Grand
Island, NY). Another aliquot was used to measure the glycosaminoglycan (GAG)
content (National Diagnostics, Atlanta, GA) through an alcian blue precipitation
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reaction28,29. The last aliquot was used to quantify collagen content through the detection
of the amino acid hydroxyproline (HYP)30,31. All volumes were carefully recorded for
normalization during analysis.
Histology
Histology was performed at the University of Alabama-Birmingham Center for
Metabolic Bone Disease. After scaffolds had been cultured in the mechanical bioreactor
and ECM had been deposited across the scaffolds, one FB STIM and one FB+OB STIM
scaffold was removed from the chamber and frozen. Samples were then fixed in 10%
Neutral Buffered Formalin for at least 24 hours, then transferred to 70% ethanol (EtOH)
for complete fixation. All the samples were dehydrated through cycles of 80% EtOH x1,
95% EtOH x2, and 100% EtOH x4 then three changes of xylene prior to the infiltration
solution, 95% methyl methacrylate (MMA) and 5% dibutyl phthalate (DBP). Infiltration
solutions for all the samples were refreshed every 3 days, for a total of 4 changes. After
infiltration, the samples were embedded on edge in a solution composed by 95% MMA
and 5% DBP with 0.25% perkodox as the initiator. The samples were then exposed to
UV light for polymerization. The fully polymerized (plasticized) sample blocks were
trimmed (noting which end was the bone side) and cut to obtain 5 µm thin sections
through the longitudinal axis. There were four stains used including 1) Methylene Blue
and Basic Fuchsin, 2) Goldner’s Trichrome stain, 3) Toluidine Blue stain, and 4) Von
Kossa stain. Stained sections were then observed and by light microscopy and captured
images were analyzed using BioQuant Osteo II Software (Nashville, TN).

67

Statistics
The data was collected and averaged. The GAG and HYP were normalized to
DNA and error was propagated32. Two-way ANOVA with respect to stretching and
scaffold region with Holm-Sidak post-hoc test was performed on the necessary groups at
a significance level of α=0.05 using SigmaStat statistical software. For PCR data, after
calculating the relative change and propagating error, two-way ANOVA was performed
on relative changes with respect to scaffold region.
RESULTS
This preliminary study has three main objectives: (1) to determine gene activation
of rat stem cells on the different deposited ECM coatings on the scaffold through rt-PCR,
(2) to characterize the deposited ECM by measuring collagen and GAG content with
hydroxyproline and alcian blue methods, respectively, (3) to visually evaluate the
deposited ECM coating on the scaffolds using histology.
RT-PCR
Gene activation of rat MSCs seeded on the mechanically-stimulated scaffolds was
measured using RT-PCR. Tendon-specific, bone-specific, and fibrocartilage-specific
genes were selected for analysis. Collagen type III, decorin, osteocalcin, and aggrecan
were measured. Collagen III is the second most common collagen type in tendon3,33,34
and is also present in bone. Decorin is the primary proteoglycan found in tendon33,34.
Osteocalcin is upregulated during bone formation35. Aggrecan is the primary
proteoglycan in cartilaginous tissues3. Figure 3 shows the relative MSC gene activation
on the tendon, bone, and transition regions of the scaffold compared to the MSCs
cultured on TCP. These data represent activated tissue-specific genes in the MSCs after
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24 hours of exposure to the ECM coated scaffolds. This PCR data does not represent
how mechanical strain affected gene activation during ECM deposition on the scaffolds,
but how the MSCs react to the mechanically-stimulated ECM deposited coating on the
scaffolds. All four genes were upregulated compared to the TCP control. There were no
significant differences between any of the experimental groups, shown in Figure 3, due to
the high variance in the data. In general, the stretching had a slightly larger impact on the
osteoblast region ECM compared to the fibroblast region ECM with respect to collagen
and aggrecan. It was also observed that full scaffold mechanical stimulation, FB+OB
STIM, produces a change in deposited ECM to increase MSC collagen activation and
decrease mineralization activation compared to FB STIM scaffolds. When the OB region
is stimulated in the FB+OB STIM scaffolds, there were indications of decreased MSC
decorin expression compared to the FB STIM scaffolds. The two different mechanical
conditioning treatments did not produce a significant difference in MSC aggrecan
expression between groups but both were greater compared to the TCP control.
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FIGURE 3. Mean relative fold change with standard deviations of gene activation in
MSCs exposed to ECM depositions on scaffolds with mechanical stimulation compared
to MSCs on tissue culture plastic. Generally, the ECM deposited on the FB+OB STIM
scaffolds increased activated genes for collagen production, decreased mineralization,
decreased tendon specific GAG, and no change in fibrocartilage activation compared to
FB STIM scaffolds.

ECM Deposition
The ECM deposited on the scaffolds was characterized after removal of the MSCs
with regards to GAG and HYP deposition which was normalized to DNA. The FB STIM
scaffolds were strained with a center clamp in the transition zone of the scaffolds.
Therefore, while stretching, no cells could grow under the clamp. After 21 days, the
clamp was removed to allow cells to infiltrate this transition area for the remaining 14
days. While some cells were present in the transition area after 35 days, there was a
significant decrease in cell number compared to the FB+OB STIM scaffolds. Generally
there was more OB DNA than FB DNA on the scaffolds. Comparing the GAG/DNA for
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the OB and FB, the different stimulation regimes did not significantly affect ECM
deposition. However, there was a significant increase in the GAG/DNA deposition for
the FB STIM scaffolds compared to FB+OB STIM scaffolds within the transition region.
A similar trend appeared in the HYP/DNA data. The two different stretching regimes did
not significantly affect ECM when comparing between individual regions of the scaffold.
FBs were found to deposit significantly more collagen per cell than the OB.
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FIGURE 4. Characterization of ECM deposited on the scaffolds after 35 days of
stimulation in the mechanical bioreactor. A) Mean DNA values ± standard deviation. B)
GAG/DNA values ± standard deviation. C) Mean HYP/DNA values ± standard
deviation. *Groups are statistically different at p<0.05.
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Histology
Figure 5 shows a collage of histology slides from the four stains used on the FB
STIM scaffold sections. Each image shows the thick ECM layer that was deposited on
the surface of the scaffolds. Similar sections of the scaffold were selected for comparison
between stains. Each image is a stitched composite of approximately fifty single frames
at 10x magnification. Methylene blue and goldner trichrome stained the ECM the most
intensely. Within the FB and OB regions a thick ECM layer was found with
predominately highly aligned collagen and embedded cells as seen in Figure 6. The
ECM deposition can be seen directly in contact with the PLA fibers of the scaffold. In
some locations, the ECM layer was observed to be physically pulled away from the
fibers. This ECM observation was potentially caused during the handling and
histological processing of the scaffolds. Also, the majority of the ECM deposition
occurred at the surface of the fabric layer. There was evidence of cell penetration and
collagen deposition deeper within the fabric weave in a few isolated occurrences. There
was also a noticeable absence of deposited ECM within the transition area of the FB
STIM scaffold due to the presence of the center clamp during stimulation. Upon more
detailed examination there was no noticeable mineralization in the von kossa or trichome
staining and no fibrocartilage ECM deposition in the scaffold coating from these medium
and mechanical stimulation conditions.
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FIGURE 5. Histological staining of FB STIM scaffolds. The four stains are listed in
columns and the scaffold sections are listed in the rows. The fibroblast “tendon” region
stained for the most ECM and little to no mineralization. The center transition was
positioned under a clamp for 21 days had little observed matrix deposition. The ECM
layer is mostly highly aligned collagen seemed to stain more intensely in the FB region of
the scaffold compared to the OB region. Mineral staining for early tissue calcification
was not observed in the ECM coating. The scale bar in each image is 500 microns.
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FIGURE 6. Higher magnification (40x) of the collagenous ECM coating on the FB+OB
STIM scaffolds. (A) Toluidine blue stain of the ECM coating between the OB and
transition regions and (B) Goldner trichrome stain of the ECM coating between the FB
and transition region. Both images demonstrate multiple layers of highly aligned
collagen and high cell numbers. Image B also indicates a lack of fibrocartilage and
mineral staining. ECM can be observed in direct contact with the PLA fibers of the
scaffold, and seems to have been physically separated during specimen slide preparation.

Figure 7 shows the collagen from the FB+OB STIM scaffolds. More intense and
uniform staining of the ECM coating across the entire scaffold is shown in these
conditions. As with the FB STIM, methylene blue and goldner trichrome stained the
ECM the most intensely, but toluidine blue and von kossa were more intense on the
FB+OB STIM scaffolds. ECM deposition in the transition region is intact due to the
absence of the center clamp during stimulation. The transition images in Figure 7 show a
dense cluster on the left side of the scaffold. This cluster is an indicator thread used to
mark the midpoint of the scaffold. Since the thread was easily identified in each image,
this location was selected as the locale of the transition comparisons. As with the FB
STIM scaffolds, the ECM coating consists of a thick ECM layer of mostly highly aligned
collagen with embedded cells. Most of the coating is on the surface. No observed
mineralization or fibrocartilage was found in the ECM of the study conditions.
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FIGURE 7. Histological staining of FB+OB STIM scaffolds. The four stains are listed
in columns and the scaffold sections are listed in the rows. Similar scaffold sections were
selected to compare ECM staining. ECM deposition was uniform on the surface of the
fabrics for each section, including the transition region. The dense cluster on the left side
of the transition region is an indicator thread used to mark the midpoint of the scaffold
and was an easy target for selecting a comparable location. Collagen was highly aligned
over the entire scaffold in the direction of the tensile strain. Little to no mineralization
staining for any portion of the scaffold was observed under these study conditions. The
scale bar in each image is 500 microns.

DISCUSSION
This study investigated the feasibility of generating a tissue-specific coating on a
degradable scaffold for tendon-to-bone repair. The coating is formed by culturing
fibroblasts and osteoblasts on separate regions of the scaffold and allowing these cells to
deposit ECM. The tissue-specific ECM is further enhanced by applying mechanical
stimulation to the scaffolds and cells over 35 days in culture during ECM deposition.
This methodology is founded on the hypothesis that specific ECM can direct cells at the
injury site to regenerate the tissues necessary for enthesis repair36.
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Biomaterial based scaffolds alone have been used in the past to repair injured
ligaments at the bony interface in the ACL37-40. For example, polyester terepthalate
(PET) scaffolds had promising short term functional results, however long term
incorporation into the surrounding tissue failed37,41. ECM based scaffolds like small
intestinal submucosa (SIS) and acellular dermal matrices (ACDM) are also being used
clinically to aid in tendon repair42-44. These materials have shown very good tissue
integration and injury site remodeling, but these ECM products have much lower
mechanical properties than natural tendon or bone42-44. Therefore, a combination of a
biomaterial based scaffold to achieve short term mechanical stability with an ECM based
coating to help integrate into the surrounding tissue may provide better clinical outcomes.
Specific ECM based components are powerful tools in tissue engineering because they
can provide signals to the body’s cells to regenerate or repair the damaged site36.
Mechanical stimuli can be applied to the cells in vitro to create a more mimetic ECM
coating on the scaffold potentially promoting faster scaffold/tissue integration.
Previous studies using mechanical bioreactors have shown that constructs with
cell deposited collagen and ECM have increased mechanical strength properties
compared to static culture 25, although reported conditions of how to apply the
mechanical stimulation within the bioreactors widely vary. Strain magnitude, strain rate,
number of cycles, cycle frequency, and rest durations can all affect the how the cells
respond, and there is no consensus on the best parameter combination18. The optimal
combinations of these parameters are almost certainly specific to the cell types and
scaffold being used. Deng et al. reported using static strain to condition dermal
fibroblasts on aligned PGA fibers24. Histology showed collagen alignment compared to
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non-strained substrates and mechanical strength was greatly increased24. However,
culture time was 18 weeks which may be too long for a practical therapy. Cyclic strain
may produce results faster that static strain but can be dependent upon the strain profile.
Riboh et al. demonstrated with primary tendon cells, continuous cyclic strain decreased
cell proliferation, where as intermittent cyclic strain increased cell proliferation and
increased total collagen production23. Johsi et al. varied cyclic strain parameters and
found that ultimate tensile strength of their constructs was highest with relatively low
cycle frequency and low strain magnitudes of 2.5%. They found that cell viability
remained high for the entire study but no ECM characterization was reported25. Multiple
studies have shown increases in tendon-specific markers with mechanical stimulation.
Butler et al. and Abousleiman et al. showed increases in collagens type I and type III with
direct stimulation of MSCs 6,18and Yang et al. showed the same behavior in primary
tendon fibroblasts using various stretching regimes21. The stimulation regime used in this
study was chosen from average values of parameters described in the literature. The
chosen stretching protocol is a good starting point for how mechanical stimulation can
affect the scaffolds. Because of the number of variables associated with mechanically
straining seeded scaffolds, there are future research opportunities to fully optimize the
stretching protocol for our cell types and scaffolds.
Our cultured scaffolds demonstrated that collagen became aligned during cyclic
stimulations and cell viability remained high throughout the study. There was no
detectable mineralization in the ECM coating medium. While any potential in vitro
calcification deposited was not expected to be mature hydroxyapatite, it was expected to
see some calcium staining with the Von Kossa stain in the OB region of the scaffold45.
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Because the scaffolds used in our experiments are co-cultured with FB and OB, the
osteogenic components were decreased to prevent FB ECM calcification. A study by
Alverez-Perez et al. reported no in vitro mineralization of MSC deposited ECM on
polycaprolactone (PCL) nanofibers when osteogenic medium was not used and positive
mineralization when osteogenic medium was used46. It may have been the case that
osteogenic signals were not strong enough. While preferential mineralization in the OB
region compared to FB region would have been appreciated, the focus of this work was to
modify deposited ECM through mechanical stimulation for a tendon-to-bone repair
construct.
Even with the current mechanical stimulation parameters, an increase in tissue
specific gene activation in MSCs was observed compared to a TCP control. Increases in
collagen III, decorin, osteocalcin, and aggrecan activation were all expressed more due to
the bioreactor conditioned coating. In a study by Sadr et al, MSC bone specific genes
were activated more when exposed to cell deposited ECM compared to scaffolds alone
similar to our findings47. There are also examples of gradients of ECM based coatings on
synthetic scaffolds that can spatially upregulate gene activation across the scaffold48,49.
When comparing actual deposited ECM on the scaffold to our previous tendon/bone
scaffolds the mechanical conditioning produced a 575-720% increase in FB collagen
deposition and 250-300% in OB deposition compared to static co-culture conditions
(REF submissions). There was also an increase of 8-34% in FB GAG deposition and a
decrease of 14-30% in OB GAG deposition (REF). This suggests that the mechanical
conditioning causes more fibrous deposition in OBs and tendon like behavior in the FB.
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In conclusion, we have designed and built a mechanical bioreactor that can apply
different strains on a scaffold for different cell types to produce a more mimetic tissue
specific coating. It was observed that stretching regimes in the bioreactor can affect the
deposited ECM coating on the scaffold and tissue specific genes respond positively to the
tissue specific ECM coatings compared to tissue culture plastic. Future work will focus
on optimizing the stretching protocol for the deposited ECM coatings and evaluate the
tissue specific coating in a functional tendon-to-bone animal model.
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CHAPTER 5: PLANNED IN VIVO ANIMAL MODEL
Originally outlined in the awarded grant was an in vivo animal model planned to evaluate
the effectiveness of tissue ingrowth and attachment of a tendon-bone tissue engineered
scaffold in a rabbit tibial tendon-bone interface. This animal study had a total of 14
rabbits with 4 groups: mechanically-stimulated cultured ECM scaffolds, static cultured
ECM scaffolds, scaffolds only, and reattached tendon. Surgeries were performed on 13
of 14 rabbits with 6 of 13 unexpectedly fracturing legs in less than 72 hours, leading to
the termination of the study. These planned studies were based on published articles38
and approved by proper IACUC and ACURO channels at University of Tennessee,
University of Memphis, and USAMRMC. As such, we had no additional funds available
to repeat a potential modified animal study to re-evaluate the ECM coated scaffolds.
Therefore, a replacement study of gene activation of MSCs was performed to evaluate the
function of the mechanically stimulated tissue specific scaffolds as outlined in Chapter 4.
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CHAPTER 6: CONCLUSIONS
In the scaffolds selection study in chapter 2 we determined that the BioTape
scaffold had low mechanical strength and degraded before we could quantify ECM
deposition. The degradable PLA fabric scaffold was able to provide good mechanical
strength, while still allowing for high cell viability and deposition of collagen and GAG.
The non-degradable PET fabric had similar mechanical properties, cell viability, and
ECM deposition characteristics as the PLA scaffold. However between the two, the
degradable biomaterial is a better choice because it allows for replacement with natural
tissue as is degrades.
In chapter 3, we determined that with fluorescence cell tracking we are able to
seed the PLA scaffold in co-culture to make a tendon-specific region and a bone-specific
region on the scaffold. We also found a co-culture media formulation of alpha-MEM +
10% fetal bovine serum + 1x antibiotic/antimycotic+ 3 mM beta-glycerophosphate + 25
μg/mL of ascorbic acid to ECM deposition with low fibroblast mineralization and still
provide for osteoblast mineralization. We also determined that a transition region is
formed that has collagen and GAG amounts between the fibroblast and osteoblast
regions.
In chapter 4, we successfully applied two different strains to a single scaffold to
stimulate the tendon-region and osteoblast-region differently. The ECM that was
deposited on the scaffolds was affected by the different stretching regimes. There were
higher cell numbers and higher collagen to GAG ratio on scaffolds where both regions
were stimulated. Tissue specific stem cell gene activation was increased on the
mechanically stimulated scaffolds compared to tissue plastic.
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We have demonstrated new protocols and methodologies to seed and characterize
scaffolds for tendon-to-bone tissue engineering. Also a novel custom dual strain
bioreactor was designed and developed for use in this project. These new technologies
and methodologies will provide opportunities for future investigations and improvements
in the tendon-to-bone repair research.
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CHAPTER 7: RECOMMENDATIONS FOR FUTURE WORK
The first recommended action is to evaluate the mechanically stimulated tissue
specific scaffolds in a functional animal model. I would recommend a model similar the
one outlined in chapter 5 but with modifications. It is possible to re-do the study with a
more proximal bone tunnel in tibia to reduce mid-bone stresses. The other
recommendation is to perform the model with smaller scaffolds or use the same scaffolds
in a slightly larger animal model other than rabbit. This would reduce the bone tunnel
needed for a rabbit tibia or allow for a larger tunnel in a bigger tibia of a different animal.
I would recommend additional and more tissue specific assays to understand the
deposition of tissue specific ECM on the scaffolds. We have demonstrated ECM
deposition of collagen and GAG on the scaffolds. It would be an advantage to measure
more specific changes in ECM deposited over the scaffold. This would allow us
understand how to modify and improve our methods of cell seeding, media formulation,
and stretching regimes of the scaffolds. These more specific assays could include more
advance direct quantification through ELISA, PCR, or other assays and imaging through
immunohistochemistry and histology.
It may be beneficial to move to duplicate characterizations we have learned with a
different cell line, like primary cells. It may take a step towards a more mimetic
assembly of tissue engineering parameters. There is certainly a large opportunity to
experiment with different stretching protocols to alter the mechanical signal given to the
cells during ECM deposition. We chose a single stretching protocol from the literature,
and we have not fully optimized the stretching protocol for the cells we are using.
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